Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm And Carlton St
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-845-1110
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2006 - 2009
University at BuffaloResidency, Internal Medicine, 2003 - 2006
Shanghai Medical UniversityClass of 1992
Certifications & Licensure
NY State Medical License 2009 - 2025
MD State Medical License 2006 - 2010- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) Start of enrollment: 2015 Jun 26
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 82 citationsT-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitorsTakayoshi Yamauchi, Toshifumi Hoki, Takaaki Oba, Vaibhav Jain, Hongbin Chen
Nature Communications. 2021-03-03 - 9 citationsOptimal Care for Patients with Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer: A Review on the Role and Utility of ALK Inhibitors.Abhay Singh, Hongbin Chen
Cancer Management and Research. 2020-07-30 - 68 citationsProliferative potential and resistance to immune checkpoint blockade in lung cancer patientsSarabjot Pabla, Jeffrey M. Conroy, Mary Nesline, Sean T. Glenn, Antonios Papanicolau-Sengos
Journal for Immunotherapy of Cancer. 2019-02-01
Press Mentions
- Roswell Park Researchers Identify New Biomarker of Response to Checkpoint InhibitorsMarch 3rd, 2021
- Predisposing Factors and Radiological Features in Patients with Internal Carotid Artery Dissection or Vertebral Artery DissectionDecember 10th, 2020
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
